FSD Pharma vs MongoDB Which Performs Better?

FSD Pharma and MongoDB are two very different companies with unique offerings in the stock market. FSD Pharma is a biotech company focused on developing cannabis-based therapies, while MongoDB is a technology company specializing in database management solutions. Both stocks have seen fluctuations in recent months, with FSD Pharma facing challenges in the cannabis industry and MongoDB experiencing growth in the tech sector. Investors should carefully consider the potential risks and rewards of investing in these contrasting stocks.

FSD Pharma or MongoDB?

When comparing FSD Pharma and MongoDB, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between FSD Pharma and MongoDB.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. FSD Pharma has a dividend yield of -%, while MongoDB has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. FSD Pharma reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, MongoDB reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with FSD Pharma P/E ratio at -0.27 and MongoDB's P/E ratio at -128.40. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. FSD Pharma P/B ratio is 0.30 while MongoDB's P/B ratio is 17.13.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, FSD Pharma has seen a 5-year revenue growth of -1.00%, while MongoDB's is 1.87%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with FSD Pharma's ROE at -94.58% and MongoDB's ROE at -15.40%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $0.09 for FSD Pharma and $345.99 for MongoDB. Over the past year, FSD Pharma's prices ranged from $0.09 to $109.19, with a yearly change of 125409.77%. MongoDB's prices fluctuated between $212.74 and $509.62, with a yearly change of 139.55%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.